MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
799.27%
Quick Ratio
799.27%
Cash Ratio
361.82%
Debt to Asset Ratio
12.54%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Less accumulated depreciation
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, cur...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
41,417
34,064
41,499
35,405
Short-term investments
48,542
63,673
77,083
93,849
Prepaid expenses and other current assets
1,534
1,483
1,863
1,107
Total current assets
91,493
99,220
120,445
130,361
Total property and equipment
8,354
8,354
8,207
8,146
Less accumulated depreciation
4,106
3,701
3,318
2,957
Property and equipment, net
4,248
4,653
4,889
5,189
Operating lease right-of-use assets
1,977
2,255
2,527
2,792
Long-term investments
-
-
-
5,108
Restricted cash
195
194
203
202
Other assets
1,179
1,510
1,653
1,647
Total assets
99,092
107,832
129,717
145,299
Accounts payable
861
1,162
2,277
996
Accrued expenses and other current liabilities
9,451
8,740
12,215
12,711
Operating lease liabilities, current
1,135
1,152
1,172
1,184
Total current liabilities
11,447
11,054
15,664
14,891
Operating lease liabilities, non-current
980
1,263
1,537
1,805
Total liabilities
12,427
12,317
17,201
16,696
Common stock, 0.001 par value 500,000,000 shares authorized as of june 30, 2026 and december 31, 2025 42,847,215 and 31,648,856 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
42
38
31
31
Additional paid-in capital
398,543
389,396
387,255
384,356
Accumulated other comprehensive (loss) income
-33
4
111
112
Accumulated deficit
-311,887
-293,923
-274,881
-255,896
Total stockholders' equity
86,665
95,515
112,516
128,603
Total liabilities and stockholders' equity
99,092
107,832
129,717
145,299
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$48,542K (-49.19%↓ Y/Y)Cash and cashequivalents$41,417K (-1.14%↓ Y/Y)Prepaid expenses andother current assets$1,534K (55.11%↑ Y/Y)Total property andequipment$8,354K (8.78%↑ Y/Y)Total current assets$91,493K (-33.90%↓ Y/Y)Property and equipment,net$4,248K (-16.25%↓ Y/Y)Operating leaseright-of-use assets$1,977K (-35.22%↓ Y/Y)Other assets$1,179K (-28.42%↓ Y/Y)Restricted cash$195K (-2.99%↓ Y/Y)Less accumulateddepreciation$4,106K (57.44%↑ Y/Y)Total assets$99,092K (-37.51%↓ Y/Y)Total liabilities andstockholders' equity$99,092K (-37.51%↓ Y/Y)Total stockholders'equity$86,665K (-39.41%↓ Y/Y)Total liabilities$12,427K (-20.06%↓ Y/Y)Accumulated deficit-$311,887K (-31.23%↓ Y/Y)Accumulated othercomprehensive (loss) income-$33K (-131.13%↓ Y/Y)Additional paid-in capital$398,543K (4.72%↑ Y/Y)Total currentliabilities$11,447K (-14.77%↓ Y/Y)Operating leaseliabilities, non-current$980K (-53.66%↓ Y/Y)Common stock, 0.001 parvalue 500,000,000...$42K (35.48%↑ Y/Y)Accrued expenses andother current...$9,451K (-15.01%↓ Y/Y)Operating leaseliabilities, current$1,135K (-1.13%↓ Y/Y)Accounts payable$861K (-25.97%↓ Y/Y)

Acrivon Therapeutics, Inc. (ACRV)

Acrivon Therapeutics, Inc. (ACRV)